» Related Searches: cancer, breast cancer, drug, cancer risk, lung cancer treatment
Results 41 to 50 of 68 
A new study suggests that high doses of a best-selling drug used to treat anemia in
dialysis and cancer patients may increase the risk of heart problems … 
A new medical study suggests that high doses of a best-selling drug used to treat
anemia in dialysis and cancer patients may increase the risk of heart problems and
death … 
North American Scientific Inc. got approval from the Food and Drug Administration to
market a high-dose radiation design of its breast cancer treatment, the company said
Tuesday … 



The amount of time and the costs involved in treating cancer-induced anemia can be
significant and should be weighed when choosing a treatment plan. Clinical Drug
Investigation … 



One of the first studies to investigate the effects of a new anti-cancer drug in
patients with advanced or metastatic solid tumours has shown that it is capable of halting … 



… cancer drug in patients with advanced or metastatic solid tumours has shown that
it is capable of halting progression of the disease, and the study has provided the first
proof … 



Callisto Pharmaceuticals, Inc. KAL (FWB:CA4), a developer of new drug treatments in
the fight against cancer and other major health threats, announced that a leading
independent research firm, First Berlin … 



Receives the 2006 John A. Montgomery Award in Switzerland … 



Cancer-treatment developer Dendreon said it submitted the final portion of a
biologics license application to the FDA … 



… Drug Administration has agreed to expand the use of Genentech Inc.'s breast
cancer drug Herceptin to include women with early-stage cancer who have
undergone surgery, the company said on Thursday … 